Meet a Scientist
Francesca Marassi, Ph.D.
Professor, Cancer Metabolism and Signaling Networks Program
Our path starts here
Join us on our journey as we drive scientific research to improve patient treatments for tomorrow.
Cancer
The Institute’s Cancer Center is one of only seven NCI-designated basic cancer research centers in the nation. We couple fundamental biological research with early translational studies to find new, innovative therapies that restore hope to cancer patients and their families.
Meet a Scientist
Garth Powis, D. Phil.
Jeanne and Gary Herberger Leadership Chair in Cancer Research
Immunity
The human immune system is made up of a network of cells, tissues and organs that fight off disease. It can also turn against the body causing autoimmune disorders, such as rheumatoid arthritis, lupus, Crohn’s disease and psoriasis. Increasingly, scientists are learning how to help the body’s immune system to combat cancer.
Meet a Scientist
Adam Godzik, Ph.D.
Adjunct Professor, Bioinformatics and Structural Biology Program
Neuroscience and Aging
Diseases associated with aging and development are already a leading cause of death and disability, and their prevalence is rising fast—to give one example, by 2050, the number of Alzheimer’s patients age 65 and older may nearly triple from 5 million to 13.8 million.
Meet a Scientist
Huaxi Xu, Ph.D.
Jeanne and Gary Herberger Leadership Chair in Neuroscience Research
Meet a Scientist
Rolf Bodmer, Ph.D.
Director and Professor, Development, Aging and Regeneration Program
Sanford Children's Health Research Center
Genetic diseases in children are rare, and often incurable. Research insights into the genes and environmental factors that play a role in the development of childhood diseases are leading to better ways to more accurately diagnose, treat and cure children with disease.
Cancer
The Institute’s Cancer Center is one of only seven NCI-designated basic cancer research centers in the nation. We couple fundamental biological research with early translational studies to find new, innovative therapies that restore hope to cancer patients and their families.
Meet a Scientist
Garth Powis, D. Phil.
Jeanne and Gary Herberger Leadership Chair in Cancer Research
Meet a Scientist
Francesca Marassi, Ph.D.
Professor, Cancer Metabolism and Signaling Networks Program
Immunity
The human immune system is made up of a network of cells, tissues and organs that fight off disease. It can also turn against the body causing autoimmune disorders, such as rheumatoid arthritis, lupus, Crohn’s disease and psoriasis. Increasingly, scientists are learning how to help the body’s immune system to combat cancer.
Meet a Scientist
Adam Godzik, Ph.D.
Adjunct Professor, Bioinformatics and Structural Biology Program
Neuroscience and Aging
Diseases associated with aging and development are already a leading cause of death and disability, and their prevalence is rising fast—to give one example, by 2050, the number of Alzheimer’s patients age 65 and older may nearly triple from 5 million to 13.8 million.
Meet a Scientist
Huaxi Xu, Ph.D.
Jeanne and Gary Herberger Leadership Chair in Neuroscience Research
Meet a Scientist
Rolf Bodmer, Ph.D.
Director and Professor, Development, Aging and Regeneration Program
Sanford Children's Health Research Center
Genetic diseases in children are rare, and often incurable. Research insights into the genes and environmental factors that play a role in the development of childhood diseases are leading to better ways to more accurately diagnose, treat and cure children with disease.
Drug Discovery and Technology
SBP has the talent and resources to accelerate the development of new therapeutics.
Prebys Center
Through development and application of modern drug discovery technologies, SBP is uniquely positioned to make next-generation medicines.
Shared Resources
Our cores provide advanced technology, expertise and instrumentation to investigators.
Other Platforms
SBP innovates and maintains key technologies and partnerships to facilitate research.
Prebys Center
Through development and application of modern drug discovery technologies, SBP is uniquely positioned to make next-generation medicines.
Shared Resources
Our cores provide advanced technology, expertise and instrumentation to investigators.
Other Platforms
SBP innovates and maintains key technologies and partnerships to facilitate research.
Press Release
January 15, 2019
Muscle stem cells can drive cancer that arises in Duchenne muscular dystrophy
Paper of the Week
Intergenerational inheritance of high fat diet-induced cardiac lipotoxicity in Drosophila
Press Release
January 14, 2019
Epigenetic change causes fruit fly babies to inherit diet-induced heart disease
Press Release
January 11, 2019
Powerful microscope captures first image of “haystack” nanoscaffold that promotes cell movement
Paper of the Week
Simultaneous Loss of Both Atypical Protein Kinase C Genes in the Intestinal Epithelium Drives Serrated Intestinal Cancer by Impairing Immunosurveillance
Beaker Blog December 11, 2018
Parents gain answers about their child’s mysterious condition, thanks to SBP scientists
Read more
Press Release
December 11, 2018
Loss of two genes drives a deadly form of colorectal cancer, reveals a potential treatment
Beaker Blog November 28, 2018
World-renowned scientists speak at SBP’s symposium on a booming research area: epigenetics
Read more
Beaker Blog November 28, 2018
Scholarship honoring late SBP scientist Eric Dudl awarded at Cancer Center Open House
Read more
Beaker Blog November 27, 2018
Team SBP raises more than $30,000—and counting—for cancer research at Padres Pedal the Cause
Read more
In the News
November 21, 2018
Morphing brain DNA hints at a whole new way to treat Alzheimer’s
Events
5.7m
5.7 million Americans are living with Alzheimer’s. By 2050, this number is projected to rise to nearly 14 million. SBP research hopes to change that.
Support us
Your support is vital to accelerating scientific discoveries to improve human health.